Get the Stockscreener App
13.68
1.16%
-0.16
Pre-market:
13.68
Overview
News
Price History
Option Chain
Financials
Why FMC Down?
Discussions
Forecast
Stock Split
Dividend History
Fmc Corp stock is traded at $13.68, with a volume of 2.27M.
It is down -1.16% in the last 24 hours and down -19.48% over the past month.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
See More
Previous Close:
$13.84
Open:
$14.02
24h Volume:
2.27M
Relative Volume:
0.53
Market Cap:
$1.71B
Revenue:
$4.17B
Net Income/Loss:
$1.46B
P/E Ratio:
1.1773
EPS:
11.62
Net Cash Flow:
$493.00M
1W Performance:
-8.62%
1M Performance:
-19.48%
6M Performance:
-63.31%
1Y Performance:
-62.62%
1-Day Range:
$13.61
$14.20
1-Week Range:
$13.30
$15.11
52-Week Range:
$12.17
$44.78
Fmc Corp Stock (FMC) Company Profile
Name
Fmc Corp
Sector
Industry
Phone
215-299-6668
Address
2929 WALNUT STREET, PHILADELPHIA, PA
Compare FMC vs CTVA, NTR, CF, MOS, ICL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FMC
Fmc Corp
|
13.68 | 1.73B | 4.17B | 1.46B | 493.00M | 11.62 |
|
CTVA
Corteva Inc
|
78.00 | 53.08B | 17.40B | 1.20B | 2.82B | 1.5836 |
|
NTR
Nutrien Ltd
|
73.59 | 35.87B | 26.89B | 2.30B | 1.93B | 4.6634 |
|
CF
Cf Industries Holdings Inc
|
104.71 | 16.33B | 6.74B | 1.70B | 1.71B | 8.2952 |
|
MOS
Mosaic Company
|
26.01 | 8.50B | 11.06B | 367.80M | 212.50M | 1.16 |
|
ICL
Icl Group Ltd
|
4.90 | 6.38B | 7.15B | 280.00M | 137.88M | 0.1749 |
Fmc Corp Stock (FMC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Nov-11-25 | Resumed | Wells Fargo | Equal Weight |
| Oct-31-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-31-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-14-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Jun-23-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-25-25 | Upgrade | Mizuho | Neutral → Outperform |
| Mar-13-25 | Initiated | Goldman | Buy |
| Feb-14-25 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Feb-07-25 | Downgrade | UBS | Buy → Neutral |
| Feb-05-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-21-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-14-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-23-24 | Initiated | Citigroup | Neutral |
| Jun-26-24 | Initiated | Barclays | Equal Weight |
| Mar-01-24 | Initiated | Wolfe Research | Peer Perform |
| Feb-12-24 | Downgrade | Loop Capital | Buy → Hold |
| Feb-07-24 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Jan-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-04-24 | Initiated | ROTH MKM | Buy |
| Dec-14-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-07-23 | Downgrade | Mizuho | Buy → Neutral |
| Oct-24-23 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-24-23 | Downgrade | Goldman | Buy → Neutral |
| Oct-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-16-23 | Upgrade | Vertical Research | Hold → Buy |
| Sep-25-23 | Downgrade | Redburn Atlantic | Overweight → Neutral |
| Sep-05-23 | Downgrade | UBS | Buy → Neutral |
| Aug-21-23 | Initiated | JP Morgan | Neutral |
| Aug-04-23 | Upgrade | Credit Suisse | Underperform → Neutral |
| Jul-24-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-17-23 | Upgrade | Redburn | Neutral → Buy |
| Jan-19-23 | Resumed | Wells Fargo | Overweight |
| Jan-10-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-15-22 | Upgrade | Loop Capital | Hold → Buy |
| Jul-20-22 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jun-21-22 | Upgrade | BofA Securities | Underperform → Buy |
| Jun-13-22 | Downgrade | Redburn | Buy → Neutral |
| May-31-22 | Initiated | Credit Suisse | Underperform |
| Apr-14-22 | Downgrade | Loop Capital | Buy → Hold |
| Mar-31-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| Mar-22-22 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-22 | Reiterated | Citigroup | Buy |
| Feb-10-22 | Reiterated | Mizuho | Buy |
| Feb-10-22 | Reiterated | Monness Crespi & Hardt | Buy |
| Feb-10-22 | Reiterated | Wells Fargo | Overweight |
| Jan-31-22 | Initiated | Redburn | Buy |
| Jan-11-22 | Upgrade | Citigroup | Neutral → Buy |
| Nov-29-21 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-18-21 | Upgrade | Loop Capital | Hold → Buy |
| Oct-13-21 | Initiated | Mizuho | Buy |
| Oct-11-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-24-21 | Downgrade | Vertical Research | Buy → Hold |
| May-06-21 | Downgrade | Citigroup | Buy → Neutral |
| Feb-11-21 | Upgrade | Monness Crespi & Hardt | Neutral → Buy |
| Sep-17-20 | Initiated | UBS | Buy |
| Mar-26-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Mar-13-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Oct-16-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-16-19 | Initiated | Wells Fargo | Outperform |
| Sep-18-19 | Initiated | Exane BNP Paribas | Outperform |
| Aug-09-19 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-02-19 | Upgrade | Goldman | Neutral → Buy |
| Aug-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-13-19 | Resumed | Citigroup | Buy |
| May-20-19 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-18-19 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-21-19 | Reiterated | Jefferies | Buy |
| Mar-08-19 | Resumed | Goldman | Neutral |
| Nov-14-18 | Initiated | Buckingham Research | Buy |
| Nov-09-18 | Resumed | Loop Capital | Buy |
| Nov-05-18 | Resumed | Citigroup | Buy |
| Nov-05-18 | Resumed | Credit Suisse | Outperform |
| May-14-18 | Upgrade | Goldman | Neutral → Buy |
| May-04-18 | Upgrade | Stephens | Equal-Weight → Overweight |
View All
Fmc Corp Stock (FMC) Latest News
FMC's GC Retired In 2025 With Over $6.6M In Compensation - Law360
FMC Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
FMC Corp. stock underperforms Monday when compared to competitors - MarketWatch
2 Words That Should Make Investors Think Twice About FMC Stock - Yahoo Finance
FMC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
FMC Corporation declares 8-cent quarterly dividend - Investing.com
FMC Corporation Declares Quarterly Dividend - Finviz
FMC appoints Michael Barry to board of directors By Investing.com - Investing.com Canada
FMC appoints Michael Barry to board of directors - Investing.com
FMC Corporation Announces Election of Michael F. Barry to Board of Directors - Finviz
Ex-Quaker Houghton CEO who led 27 deals joins FMC's board - Stock Titan
FMC Corp Stock Re-Rates On Cost Cuts And Lawsuits: Opportunity Or Value Trap? - AD HOC NEWS
FMC CORP SEC 10-K Report - TradingView
FMC Should I Buy - Intellectia AI
FMC Corp. stock underperforms Thursday when compared to competitors - MarketWatch
2 Top Bargain Stocks Ready for a Bull Run - The Motley Fool
Analysis of Insider Buying Activity at FMC Corp. - Intellectia AI
FMC at Bank of America Conference: Strategic Plans Unveiled - Investing.com
[Form 4] FMC CORP Insider Trading Activity - Stock Titan
FMC Corp Stock Rises — What Did The CEO Say To Drive Rally? - Asianet Newsable
FMC Considers Sale Process, Stock Rises 7% - Intellectia AI
FMC Corp. stock outperforms competitors on strong trading day - MarketWatch
FMC Corp. Hits Day High with 7.85% Surge in Strong Intraday Performance - Markets Mojo
FMC Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
FMC’s Rimisoxafen Receives Historic Dual Mode of Action Classification from HRAC - iGrow News
FMC Corporation Receives Industry's First Dual Mode of Action Herbicide Classification for Rimisoxafen - Finviz
Cardinal Health and FMC Corporation have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Bear of the Day: FMC Corp. (FMC) - The Globe and Mail
FMC Corporation Faces Revenue Decline and Strategic Options After Q4 Earnings Miss - Intellectia AI
FMC Corporation Faces Earnings Setbacks, Stock Under Pressure - Intellectia AI
Is FMC Stock a Buy Now or a Falling Knife? - Yahoo Finance
FMC Corp (FMC) Trading Down 3.63% on Feb 20 - GuruFocus
FMC and the Two-Engine Dilemma: When the Present Devours the Future - global-agriculture.com
FMC (NYSE:FMC) Given New $20.00 Price Target at Mizuho - Defense World
FMC and Corteva Partner to Expand Access to Fluindapyr Fungicide - MSN
FMC Corporation (NYSE:FMC) Short Interest Update - MarketBeat
Mizuho Maintains FMC Rating, Lowers Price Target to $20.00 | FMC Stock News - GuruFocus
FMC price target lowered to $20 from $21 at Mizuho - TipRanks
FMC Corporation (NYSE:FMC) Given Consensus Recommendation of "Reduce" by Brokerages - MarketBeat
FMC Corporation (NYSE:FMC) Given Consensus Recommendation of “Reduce” by Brokerages - Defense World
Mizuho Securities Maintains FMC Corp(FMC.US) With Buy Rating, Cuts Target Price to $20 - 富途牛牛
FMC Corporation: High-Risk Play In Fertilizers That I'm Unwilling To Enter (NYSE:FMC) - Seeking Alpha
Lessons for Life | Olivia Pfeiffer - Villanova University
Will FMC Corporation stock profit from fiscal stimulusJuly 2025 Analyst Calls & Verified Technical Trade Signals - mfd.ru
CEO Change: Can FMC Corporation be the next market leaderWatch List & Safe Entry Trade Reports - baoquankhu1.vn
FMC Posts $2.2 Billion Loss, Launches Strategic Review Including Possible Sale - PHILADELPHIA.Today
Is FMC Corporation stock heavily shortedWeekly Trend Recap & Risk Controlled Daily Plans - mfd.ru
FMC (FMC) expects tariff headwinds for Q1 as Q4 earnings slip - MSN
FMC Corp. stock underperforms Friday when compared to competitors - MarketWatch
FMC Corp.: How a Quiet Chemistry Powerhouse Became a Strategic Tech Product in Global Food Security - AD HOC NEWS
FMC Weighs Full Sale As Debt Pressures And Patent Risks Mount - simplywall.st
Fmc Corp Stock (FMC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.91%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):